BioMarin Pharmaceutical

ISIN US09061G1013

 | 

WKN 924801

Market cap (in EUR)
9,833 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Quote

Description

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Chart

Financials

Key metrics

Market capitalisation, EUR 9,833 m
EPS, EUR 1.58
P/B ratio 1.8
P/E ratio 32.4
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 2,874 m
Net income, EUR 309 m
Profit margin 10.76%

What ETF is BioMarin Pharmaceutical in?

There are 13 ETFs which contain BioMarin Pharmaceutical. All of these ETFs are listed in the table below. The ETF with the largest weighting of BioMarin Pharmaceutical is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.02%
Equity
World
Multi-Asset Strategy
937
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
14
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist 0.01%
Equity
North America
Social/Environmental
Climate Change
35
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.02%
Equity
World
Multi-Asset Strategy
69
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.01%
Equity
World
Multi-Asset Strategy
722
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.01%
Equity
World
Multi-Asset Strategy
207
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.01%
Equity
World
Social/Environmental
480
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.17%
Equity
United States
Small Cap
187
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.83%
Equity
United States
Health Care
Biotech
47
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.02%
Equity
North America
Social/Environmental
24
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
91
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.01%
Equity
World
Multi-Asset Strategy
36
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.01%
Equity
World
Multi-Asset Strategy
92

Performance

Returns overview

YTD -1.77%
1 month -0.71%
3 months +13.53%
6 months +9.99%
1 year -21.68%
3 years -43.17%
5 years -22.85%
Since inception (MAX) -40.66%
2025 -19.79%
2024 -27.75%
2023 -8.14%
2022 +20.96%

Monthly returns in a heat map

Risk

Risk metrics in this section:
 
  • Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
  • Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
  • Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
ETF returns include dividend payments (if applicable).
Show more Show less

Risk overview

Volatility 1 year 37.65%
Volatility 3 years 32.58%
Volatility 5 years 31.79%
Return per risk 1 year -0.58
Return per risk 3 years -0.53
Return per risk 5 years -0.16
Maximum drawdown 1 year -34.70%
Maximum drawdown 3 years -51.92%
Maximum drawdown 5 years -59.31%
Maximum drawdown since inception -68.14%

Rolling 1 year volatility

— Les données utilisées sont mises à disposition par Trackinsight, etfinfo, Xignite Inc., gettex, FactSet et justETF GmbH.

Les cotations sont des cotations en temps réel (gettex), des cotations boursières retardées de 15 minutes ou des VNI (quotidiennes publiées par le fournisseur du fonds). Par défaut, les rendements des ETF incluent les paiements de dividendes (le cas échéant). Aucune garantie n'est donnée quant à l'exhaustivité, la précision et l'exactitude des informations affichées.